Advertisement
Screener

ACLARION, INC. (ACON) ROE

ACLARION, INC. (ACON) ROE

  • 2026-06-30: ROE -54.09%.
  • 2026-03-31: ROE -40.96%.
  • 2025-12-31: ROE -56.36%.
  • 2025-09-30: ROE -58.67%.

Complete source-backed roe history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-54.09%
2026-03-31-40.96%
2025-12-31-56.36%
2025-09-30-58.67%
2025-06-30-49.29%
2025-03-31-42.02%
2024-12-31-720.88%
2024-09-30-249.77%
2024-06-30-359.31%
2024-03-31-244.55%
2023-12-31674.64%
2023-09-30554.44%
2023-06-30-51116.70%
2023-03-31-650.29%
2022-12-31-317.55%
2022-09-30-243.40%
2022-06-30-199.49%
2022-03-3138.26%
2021-12-3138.58%

Annual ROE

DateROE
2025-12-31-56.36%
2024-12-31-720.88%
2023-12-31674.64%
2022-12-31-317.55%
2021-12-3138.58%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45